PODCAST: Big merger in the pharmaceutical industry
Share Now on:
Airing on Thursday, May 7, 2015: One of the world’s biggest drug companies has moved to outsource the process of deciding who is allowed into its experimental drug trials.Johnson & Johnson is setting up what’s called a “compassionate use” panel to help it make these life & death decisions. Staying in the theme of pharmaceuticals, Alexion announced it was buying Syngeva for $8.4 billion earlier this week. And it’s election day in the U.K. today. Inequality has been a key theme of the campaign. We’ll see how tax loopholes impact the results today.
We’re here to help you navigate this changed world and economy.
Our mission at Marketplace is to raise the economic intelligence of the country. It’s a tough task, but it’s never been more important.
In the past year, we’ve seen record unemployment, stimulus bills, and reddit users influencing the stock market. Marketplace helps you understand it all, will fact-based, approachable, and unbiased reporting.
Generous support from listeners and readers is what powers our nonprofit news—and your donation today will help provide this essential service. For just $5/month, you can sustain independent journalism that keeps you and thousands of others informed.